| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8700526 | Journal of Oral and Maxillofacial Surgery | 2017 | 9 Pages |
Abstract
BoT-A therapy provides significant relief for approximately one third of patients with refractory masticatory muscle pain. Therapy is associated with a mild risk of adverse effects. The presence of muscle hypertrophy, occurrence of an adverse effect, and concurrent use of opioid analgesics were found to be predictors of outcome response.
Related Topics
Health Sciences
Medicine and Dentistry
Dentistry, Oral Surgery and Medicine
Authors
Shehryar N. BDS, MS, Steven J. DDS, DMedSc, Nicole DDS, MS, David A. DMD, BDS,